More than 40% women with asthma may develop COPD Medha Baranwal Baranwal14 Aug 2018 7:20 PM ISTA new study published in the Annals of the American Thoracic Society finds that more than 4 in 10 women with asthma may develop the chronic...
Factors that may predict ARDS in burn patients identifed Medha Baranwal Baranwal31 Aug 2018 7:20 PM ISTThe researchers, for the first time, have devised a model to identify the risk of acute respiratory distress syndrome (ARDS) in patients with burn...
Testosterone replacement therapy slows progression of COPD Vinay Singh singh14 Sept 2018 7:25 PM ISTA new study published in the journal Chronic Respiratory Disease has found that testosterone replacement therapy may slow disease progression of the...
Air pollution major cause of increased respiratory disease burden in India: Lancet Medha Baranwal Baranwal15 Sept 2018 8:28 PM ISTIndia, having 18% of the global population contributes to 32% of the global burden of respiratory diseases, with COPD (chronic obstructive pulmonary...
Simple test for viral infections could reduce antibiotic use Medha Baranwal Baranwal17 Sept 2018 8:20 PM ISTPoint of care respiratory viral testing (POCT) -- a quick and easy test for viral infections -- can reduce unnecessary antibiotic use and hospital...
Targeted lung denervation new safe treatment for COPD Medha Baranwal Baranwal20 Sept 2018 7:25 PM ISTResults from the AIRFLOW 2 phase II clinical trial have shown that a technique called Targeted Lung Denervation (TLD) involving the opening of...
GOLD COPD Guidelines Revisited Dr. Kamal Kant Kohli Kohli20 Sept 2018 7:03 PM ISTGlobal Initiative for Chronic Obstructive Lung Disease (GOLD) released new its findings and recommendations on COPD to update and address the role of...
Use of wood or coal for cooking increases risk of respiratory diseases and death Vinay Singh singh22 Sept 2018 7:20 PM ISTLong-term use of solid fuels for cooking was associated with significantly elevated risks of hospitalization or death from both acute and chronic...
Revefenacin may be first once-daily, long-acting treatment for COPD Vinay Singh singh24 Sept 2018 8:20 PM ISTPositive results from Phase 3 clinical program for YUPELRI™(revefenacin) inhalation showed reductions in the rates of chronic obstructive pulmonary...
Albuminuria may also be a Biomarker for COPD Hina Zahid1 Oct 2018 8:20 PM ISTAccording to new research, Albuminuria, a commonly used biomarker of kidney disease may also indicate COPD. The findings of study have been published...
Researchers find no long term benefit of Oxygen in COPD Vinay Singh singh16 Oct 2018 8:20 PM ISTA new study published in The Journal of the American Osteopathic Association reveals that long-term oxygen therapy does not decrease the risk for...
Revefenacin has acceptable cardiovascular safety in COPD Vinay Singh singh21 Oct 2018 7:05 PM ISTRevefenacin, a once-daily lung selective muscarinic receptor antagonist for nebulization does not prolong QT interval and offers an acceptable 52...
